Shafer Michael D

Shafer Michael D, Executive Vice President at Thermo Fisher Scientific (TMO), has demonstrated a clear selling bias in recent insider transactions, with $9.7 million in total sales outweighing $2.8 million in purchases across 26 filings. All activity has been concentrated in TMO shares, with no trades in other companies. The most significant disposals occurred on November 25, 2025, when Shafer executed two large sales totaling $6.44 million—a $1.35 million transaction and a $5.09 million sale—alongside smaller acquisitions worth $2.81 million that same day. More recently, Shafer continued reducing positions with an $802,536 sale on March 11, 2026, following three smaller February 28, 2026 dispositions totaling $425,147 through transactions coded as "F" (likely representing tax withholdings or option exercises). The pattern shows consistent divestment, with no buys recorded in the most recent four transactions. Smaller periodic sales appear alongside larger bulk disposals, suggesting ongoing portfolio rebalancing rather than a single exit event. While some filings with $0 value indicate awards or adjustments without immediate monetary impact, the overall trend leans toward monetization of holdings. The transactions span both open-market sales ("S") and derivative-related activity ("M" and "F"), reflecting a mix of outright share disposals and transactions tied to equity compensation. The absence of recent purchases contrasts with the November 2025 buy-sell activity, marking a shift toward net reduction in exposure to TMO stock.